These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6990548)

  • 21. The binding of purified factor VIII/von Willebrand factor to collagens of differing type and form.
    Scott DM; Griffin B; Pepper DS; Barnes MJ
    Thromb Res; 1981 Dec 1-15; 24(5-6):467-72. PubMed ID: 6806932
    [No Abstract]   [Full Text] [Related]  

  • 22. Von Willebrand protein binds to extracellular matrices independently of collagen.
    Wagner DD; Urban-Pickering M; Marder VJ
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):471-5. PubMed ID: 6320190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of succinylation and dodecyl, succinylation on bovine factor VIII/von Willebrand factor complex.
    Thuy LP; Brown JE; Baugh RF; Hougie C
    Thromb Res; 1980 May 1-15; 18(3-4):305-13. PubMed ID: 6774433
    [No Abstract]   [Full Text] [Related]  

  • 24. Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens.
    Santoro SA
    Thromb Res; 1981 Mar; 21(6):689-91. PubMed ID: 6791300
    [No Abstract]   [Full Text] [Related]  

  • 25. Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.
    Fukui H; Takase T; Ikari H; Murakami Y; Okubo Y; Nakamura K
    Br J Haematol; 1979 Aug; 42(4):637-46. PubMed ID: 314304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmin digestion of factor VIII: characterization of the breakdown products with respect to antigenicity and von Willebrand activity.
    Guisasola JA; Cockburn CG; Hardisty RM
    Thromb Haemost; 1978 Oct; 40(2):302-15. PubMed ID: 153594
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulin-like and diabetogenic effects of growth hormone in healthy subjects, diabetics, and low insulin responders.
    Adamson U; Efendic S
    J Clin Endocrinol Metab; 1979 Sep; 49(3):456-61. PubMed ID: 468979
    [No Abstract]   [Full Text] [Related]  

  • 28. [Von Willebrand's syndrome (author's transl)].
    Larrieu MJ; Meyer D; Ardaillou N
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):371-82. PubMed ID: 303357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine diphosphate induces binding of von Willebrand factor to human platelets.
    Fujimoto T; Hawiger J
    Nature; 1982 May; 297(5862):154-6. PubMed ID: 6281653
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased von Willebrand factor in diabetes mellitus.
    Lufkin EG; Fass DN; O'Fallon WM; Bowie EJ
    Metabolism; 1979 Jan; 28(1):63-6. PubMed ID: 310504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
    Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
    Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial incidence of precipitating antibodies in von Willebrand's disease: a study of four cases.
    Ruggeri ZM; Ciavarella N; Mannucci PM; Molinari A; Dammacco F; Lavergne JM; Meyer D
    J Lab Clin Med; 1979 Jul; 94(1):60-75. PubMed ID: 112210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of von Willebrand factor in subjects with isolated impaired fasting glucose.
    Coban E; Bostan F
    Med Sci Monit; 2009 Apr; 15(4):CR194-7. PubMed ID: 19333205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jan 1-15; 17(1-2):215-23. PubMed ID: 6769177
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction of porcine von Willebrand factor (platelet aggregating factor) with human platelets.
    Finlay TH; Marcus DL; Kowalski S; Silber P
    Biochim Biophys Acta; 1981 Jan; 672(1):79-88. PubMed ID: 6260227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.
    Mannucci PM; Canciani MT; Rota L; Donovan BS
    Br J Haematol; 1981 Feb; 47(2):283-93. PubMed ID: 6781527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1980 Oct; 110(40):1456-8. PubMed ID: 6792697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).
    Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H
    Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.